_×
Human IGSF8 Gene cDNA Clone (full-length ORF Clone)
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Gene Products > Human cDNA Clones > Human IGSF8 Gene cDNA Clone (full-length ORF Clone)

Human IGSF8 Gene cDNA Clone (full-length ORF Clone)

Catalog Vector (Price) Quantity In Stock Operation
HG13435-G





  YES

*  pCMV vectors are ALL featured with a CMV promoter and a hygromycin-resistance (hygro) gene. These plasmids can be used directly in mammalian cell expression. Learn more about pCMV vectors.
    Notice: Additional handling time(2-3 weeks) may be required if a pCMV vector is selected.

Antibody Production Services

IGSF8 cDNA Clone Datasheet

 

IGSF8 cDNA Clone Product Information

Gene Bank Ref.ID: NM_052868.4

cDNA Size:

1842

Gene Synonym:

EWI2; PGRL; CD316; EWI-2; KCT-4; CD81P3; LIR-D1; IGSF8

Source: Human

IGSF8 cDNA Clone Description

cDNA Description:

ORF Clone of Homo sapiens immunoglobulin superfamily, member 8 DNA.

Vector: Cloning Vector: pGEM-T Vector

Expression Vectors: pCMV/hygro, pCMV/hygro-Myc, pCMV/hygro-His, pCMV/hygro-HA, pCMV/hygro-FLAG

Sequence Description: Identical with the Gene Bank Ref.ID sequence.

IGSF8 cDNA Clone Shipping

  1. 5-10μg Plasmid DNA is shipped on Whatman FTA elute card (Cat. No.: WB120410) at room temperature.
  2. It would take 7-14 days for delivery typically. For bulk orders, additional 1-2 weeks would be needed.

IGSF8 cDNA Clone Usage Protocol

  1. Cut along the circle edge of the spot (arrow points to) to get the filter paper.
  2. Transfer the filter paper to a 1.5ml microfuge tube containing 150-200 μl of sterile H2O Ensure the filter is completely immersed in the H2O Briefly centrifuge the tube for 10 seconds.
  3. Incubate the tube at 95℃ for 15-30 min.
  4. At the end of the incubation pulse vortex, or gently tap the tube.
  5. Briefly centrifuge for 30 seconds, to separate the matrix from the elute. The elute now contains the purified DNA.

IGSF8 cDNA Clone Sequence and Quality Control

Sequence:

1        ATGGGCGCCC TCAGGCCCAC GCTGCTGCCG CCTTCGCTGC CGCTGCTGCT GCTGCTAATG
61       CTAGGAATGG GATGCTGGGC CCGGGAGGTG CTGGTCCCCG AGGGGCCCTT GTACCGCGTG
121      GCTGGCACAG CTGTCTCCAT CTCCTGCAAT GTGACCGGCT ATGAGGGCCC TGCCCAGCAG
181      AACTTCGAGT GGTTCCTGTA TAGGCCCGAG GCCCCAGATA CTGCACTGGG CATTGTCAGT
241      ACCAAGGATA CCCAGTTCTC CTATGCTGTC TTCAAGTCCC GAGTGGTGGC GGGTGAGGTG
301      CAGGTGCAGC GCCTACAAGG TGATGCCGTG GTGCTCAAGA TTGCCCGCCT GCAGGCCCAG
361      GATGCCGGCA TTTATGAGTG CCACACCCCC TCCACTGATA CCCGCTACCT GGGCAGCTAC
421      AGCGGCAAGG TGGAGCTGAG AGTTCTTCCA GATGTCCTCC AGGTGTCTGC TGCCCCCCCA
481      GGGCCCCGAG GCCGCCAGGC CCCAACCTCA CCCCCACGCA TGACGGTGCA TGAGGGGCAG
541      GAGCTGGCAC TGGGCTGCCT GGCGAGGACA AGCACACAGA AGCACACACA CCTGGCAGTG
601      TCCTTTGGGC GATCTGTGCC CGAGGCACCA GTTGGGCGGT CAACTCTGCA GGAAGTGGTG
661      GGAATCCGGT CAGACTTGGC CGTGGAGGCT GGAGCTCCCT ATGCTGAGCG ATTGGCTGCA
721      GGGGAGCTTC GTCTGGGCAA GGAAGGGACC GATCGGTACC GCATGGTAGT AGGGGGTGCC
781      CAGGCAGGGG ACGCAGGCAC CTACCACTGC ACTGCCGCTG AGTGGATTCA GGATCCTGAT
841      GGCAGCTGGG CCCAGATTGC AGAGAAAAGG GCCGTCCTGG CCCACGTGGA TGTGCAGACG
901      CTGTCCAGCC AGCTGGCAGT GACAGTGGGG CCTGGTGAAC GTCGGATCGG CCCAGGGGAG
961      CCCTTGGAAC TGCTGTGCAA TGTGTCAGGG GCACTTCCCC CAGCAGGCCG TCATGCTGCA
1021     TACTCTGTAG GTTGGGAGAT GGCACCTGCG GGGGCACCTG GGCCCGGCCG CCTGGTAGCC
1081     CAGCTGGACA CAGAGGGTGT GGGCAGCCTG GGCCCTGGCT ATGAGGGCCG ACACATTGCC
1141     ATGGAGAAGG TGGCATCCAG AACATACCGG CTACGGCTAG AGGCTGCCAG GCCTGGTGAT
1201     GCGGGCACCT ACCGCTGCCT CGCCAAAGCC TATGTTCGAG GGTCTGGGAC CCGGCTTCGT
1261     GAAGCAGCCA GTGCCCGTTC CCGGCCTCTC CCTGTACATG TGCGGGAGGA AGGTGTGGTG
1321     CTGGAGGCTG TGGCATGGCT AGCAGGAGGC ACAGTGTACC GCGGGGAGAC TGCCTCCCTG
1381     CTGTGCAACA TCTCTGTGCG GGGTGGCCCC CCAGGACTGC GGCTGGCCGC CAGCTGGTGG
1441     GTGGAGCGAC CAGAGGACGG AGAGCTCAGC TCTGTCCCTG CCCAGCTGGT GGGTGGCGTA
1501     GGCCAGGATG GTGTGGCAGA GCTGGGAGTC CGGCCTGGAG GAGGCCCTGT CAGCGTAGAG
1561     CTGGTGGGGC CCCGAAGCCA TCGGCTGAGA CTACACAGCT TGGGGCCCGA GGATGAAGGC
1621     GTGTACCACT GTGCCCCCAG CGCCTGGGTG CAGCATGCCG ACTACAGCTG GTACCAGGCG
1681     GGCAGTGCCC GCTCAGGGCC TGTTACAGTC TACCCCTACA TGCATGCCCT GGACACCCTA
1741     TTTGTGCCTC TGCTGGTGGG TACAGGGGTG GCCCTAGTCA CTGGTGCCAC TGTCCTTGGT
1801     ACCATCACTT GCTGCTTCAT GAAGAGGCTT CGAAAACGGT GA

 

Quality Control:cDNA sequencing results is available upon request.

 

 

PGRL / IGSF8 related areas, pathways, and other information

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"